First reports of adverse drug reactions

First reports of adverse drug reactions Drugs Ther Perspect (2017) 33:429 DOI 10.1007/s40267-017-0435-5 DRUG REACTIONS AND INTERACTIONS Springer International Publishing AG 2017 Table 1 contains an overview of first published case reports adverse drug reactions sourced from journals, scientific of adverse drug reactions identified in the international lit- meetings, media releases, regulatory agency websites, and erature in recent weeks by Adis Insight. As part of its drug bulletins from the National Centres that participate in the alerting service, Adis Insight provides summaries of recent WHO International Drug Monitoring Programme. Table 1 First published reports of adverse drug reactions recently identified by Reactions Weekly Drug and adverse reaction References Clozapine: DRESS syndrome (serious) Hassine H, Ouali U, Ouertani A, et al. Clozapine-induced DRESS syndrome with multiple and rare organ involvement. Asian J Psychiatr. 2017;28:146–7. doi:10. 1016/j.ajp.2017.04.013 Dantrolene: slurred speech Low SA, Robbins W, Tawfik VL. Complex management of a patient with refractory primary erythromelalgia lacking a SCN9A mutation. J Pain Res. 2017;10:973–7. doi:10.2147/JPR.S129661 Nivolumab: cryoglobulinaemia (serious) Pellegrino B, Musolino A, Tiseo M. Anti-PD-1-related cryoglobulinemia during treatment with nivolumab in NSCLC patient. Ann Oncol. 2017;28(6):1405–6. doi:10.1093/annonc/mdx126 Phenobarbital: vasculitis (serious) Fathallah N, Ladhari C, Slim R, et al. Vasculitis induced by phenobarbital with cross- reactivity to carbamazepine. Therapie. 2017;72(3):387–9. doi:10.1016/j.therap. 2016.07.006 Polylactic acid: late-onset methicillin-resistant Choi M, Cheon JS, Choi WY, et al. Late-onset methicillin-resistant staphylococcus Staphylococcus aureus infection (serious) aureus infection after facial poly-L-lactic acid injection. Arch Plast Surg. 2017;44(3):248–9. doi:10.5999/aps.2017.44.3.248 Qingdai compound: ischaemic bowel disease and Zhang Z-M, Lin X-C, Ma L, et al. Ischemic or toxic injury: a challenging diagnosis stenosis of the sigmoid colon (serious) and treatment of drug-induced stenosis of the sigmoid colon. World J Gastroenterol. 2017;23(21):3934–44. doi:10.3748/wjg.v23.i21.3934 Ticagrelor: Sweet’s syndrome (serious) Ikram S, Veerappan Kandasamy V. Ticagrelor-induced Sweet syndrome: an unusual dermatologic complication after percutaneous coronary intervention. Cardiovasc Interv Ther. 2017;32(3):244–6. doi:10.1007/s12928-016-0398-9 An event is serious (US FDA MedWatch definition) when the patient outcome is death, life threatening, hospitalization, disability, congenital anomaly or requires intervention to prevent permanent impairment or damage DRESS drug reaction with eosinophilia and systemic symptoms http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Drugs & Therapy Perspectives Springer Journals

First reports of adverse drug reactions

Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/first-reports-of-adverse-drug-reactions-0uhjHO5iiE
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG
Subject
Pharmacy; Pharmacy; Pharmacotherapy
ISSN
1172-0360
eISSN
1179-1977
D.O.I.
10.1007/s40267-017-0435-5
Publisher site
See Article on Publisher Site

Abstract

Drugs Ther Perspect (2017) 33:429 DOI 10.1007/s40267-017-0435-5 DRUG REACTIONS AND INTERACTIONS Springer International Publishing AG 2017 Table 1 contains an overview of first published case reports adverse drug reactions sourced from journals, scientific of adverse drug reactions identified in the international lit- meetings, media releases, regulatory agency websites, and erature in recent weeks by Adis Insight. As part of its drug bulletins from the National Centres that participate in the alerting service, Adis Insight provides summaries of recent WHO International Drug Monitoring Programme. Table 1 First published reports of adverse drug reactions recently identified by Reactions Weekly Drug and adverse reaction References Clozapine: DRESS syndrome (serious) Hassine H, Ouali U, Ouertani A, et al. Clozapine-induced DRESS syndrome with multiple and rare organ involvement. Asian J Psychiatr. 2017;28:146–7. doi:10. 1016/j.ajp.2017.04.013 Dantrolene: slurred speech Low SA, Robbins W, Tawfik VL. Complex management of a patient with refractory primary erythromelalgia lacking a SCN9A mutation. J Pain Res. 2017;10:973–7. doi:10.2147/JPR.S129661 Nivolumab: cryoglobulinaemia (serious) Pellegrino B, Musolino A, Tiseo M. Anti-PD-1-related cryoglobulinemia during treatment with nivolumab in NSCLC patient. Ann Oncol. 2017;28(6):1405–6. doi:10.1093/annonc/mdx126 Phenobarbital: vasculitis (serious) Fathallah N, Ladhari C, Slim R, et al. Vasculitis induced by phenobarbital with cross- reactivity to carbamazepine. Therapie. 2017;72(3):387–9. doi:10.1016/j.therap. 2016.07.006 Polylactic acid: late-onset methicillin-resistant Choi M, Cheon JS, Choi WY, et al. Late-onset methicillin-resistant staphylococcus Staphylococcus aureus infection (serious) aureus infection after facial poly-L-lactic acid injection. Arch Plast Surg. 2017;44(3):248–9. doi:10.5999/aps.2017.44.3.248 Qingdai compound: ischaemic bowel disease and Zhang Z-M, Lin X-C, Ma L, et al. Ischemic or toxic injury: a challenging diagnosis stenosis of the sigmoid colon (serious) and treatment of drug-induced stenosis of the sigmoid colon. World J Gastroenterol. 2017;23(21):3934–44. doi:10.3748/wjg.v23.i21.3934 Ticagrelor: Sweet’s syndrome (serious) Ikram S, Veerappan Kandasamy V. Ticagrelor-induced Sweet syndrome: an unusual dermatologic complication after percutaneous coronary intervention. Cardiovasc Interv Ther. 2017;32(3):244–6. doi:10.1007/s12928-016-0398-9 An event is serious (US FDA MedWatch definition) when the patient outcome is death, life threatening, hospitalization, disability, congenital anomaly or requires intervention to prevent permanent impairment or damage DRESS drug reaction with eosinophilia and systemic symptoms

Journal

Drugs & Therapy PerspectivesSpringer Journals

Published: Aug 7, 2017

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from Google Scholar, PubMed
Create lists to organize your research
Export lists, citations
Access to DeepDyve database
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off